Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Search

Top

ACELRX PHARMACEUTICALS, INC. Redwood City CA USA

UEI: SLED_C9BC1A740EC55D9A

ACELRX PHARMACEUTICALS, INC. Redwood City CA USA is a federal contractor, registered under UEI SLED_C9BC1A740EC55D9A. It has been awarded $3,559,366 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include Department Of Defense.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_C9BC1A740EC55D9A

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

AcelRx Pharmaceuticals, Inc. specializes in the provision of FDA-approved pharmaceutical products. Their core capabilities include the supply and distribution of brand-name medications, specifically DSUVIA, for medical research and clinical applications. The company has experience supporting the US...

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

1

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency

Department Of Defense$3.6M100%

Awards by NAICS

325412 - Pharmaceutical Preparation Manufacturing$3.6M100%

Awards by Agency Over Time

Awards by Place of Performance

Compete with ACELRX PHARMACEUTICALS, INC. Redwood City CA USA

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for ACELRX PHARMACEUTICALS, INC. Redwood City CA USA

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Join 750+ contractors already using CLEATUS

Open opportunities in ACELRX PHARMACEUTICALS, INC. Redwood City CA USA's top NAICS codes and agencies

Antibodies Elution Kit Supplier (NSN 6550-01-346-4878)This subcontract involves the supply of finished Antibodies Elution Kits, identified by NSN 6550-01-346-4878, for prime contractors serving the Department of Defense Medical Supply Chain. The required kits must contain concentrated wash, eluting, and buffering solutions designed for the rapid acid elution of antibodies from red blood cells. All deliverables must strictly adhere to FDA regulations, MIL-STD-2073-1E packaging requirements, and Medical Marking Standard No. 1. The scope of work requires the delivery of two complete kits to Keesler AFB, with each kit maintaining a minimum shelf-life of one month. This procurement falls under NAICS code 325412 and is managed through the DLA Troop Support Medical Supply Chain.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 20 hours ago

DEADLINE

Gabapentin Capsules SupplyThis subcontract involves the supply of FDA-regulated Gabapentin Capsules (100 MG) to support prime contractors on Department of Defense medical supply chain projects. The scope of work requires the manufacture or procurement of ten bottles of capsules that strictly adhere to FDA regulations and USP Controlled Room Temperature standards of 25 degrees Celsius. To maintain a non-extendable shelf life of 36 months, all products must be handled in FDA-approved facilities and transported using climate-monitored shipping containers. The contract is managed by the Medical Supply Chain Pharm FSA and requires full compliance with the Buy American Act. Performance will take place in Washington, DC, under NAICS code 325412. Interested parties must note the response deadline of November 16, 2026, to ensure all regulatory and delivery specifications are met for this pharmaceutical procurement.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

Supplier of Hypoallergenic Soft Tissue Massage CreamThis subcontract involves the supply of non-greasy, hypoallergenic soft tissue massage cream for prime contractors supporting the Medical Supply Chain Pharm FSA under the Department of Defense. The supplier must provide products that strictly adhere to FDA regulations and meet the specifications of NSN 6508017007944. To ensure product integrity, items must be stored in heated environments maintained at 40 degrees Fahrenheit or above. The contract requires the delivery of six 15 oz containers to Fort Polk, Louisiana, on a FOB Destination basis. All packaging and labeling must comply with MIL-STD-2073-1E, MIL-STD-129, and Medical Marking Standard No. 1. This procurement falls under NAICS code 325412, with a response deadline set for November 16, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

Povidone-Iodine Cleansing Solution ManufacturerThis subcontract involves the manufacture and supply of Povidone-Iodine Cleansing Solution for prime contractors supporting MEDICAL SUPPLY CHAIN PHARM FSA projects under the Department of Defense. The solution must be produced according to USP standards, featuring a 7.5% active ingredient and a shelf life of 36 months. The product is to be delivered in one-gallon bottles, which must include SDS and Hazardous Communication Standard labels in accordance with 29 C.F.R. 1910.1200. Additionally, the manufacturer must ensure full compliance with the Buy American Act. Performance for this contract is designated for FPO 96665.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

Pan-Africa Polyvalent Antivenin SupplierThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Pan-Africa polyvalent equine F(ab)2 immunoglobulin fragments antivenin. The biological therapeutics are designed to treat snakebite envenomation from 25 different species and are intended for prime contractors fulfilling DLA supply contracts. The delivery requirement consists of 6 cases containing a total of 216 vials, shipped FOB Destination. To qualify, the supplier must possess pharmaceutical manufacturing facilities and maintain strict compliance with FDA regulatory approvals. Additionally, all deliverables must adhere to MIL-STD-2073-1E and RP001 DLA Packaging Requirements. The contract falls under NAICS code 325412, with a response deadline set for November 16, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

POVIDONE-IODINE CLEANS

Solicitation # SPE2DP-27-T-0271

This procurement involves the supply of Povidone-Iodine Cleansing Solution, USP, with a 7.5% active ingredient for external use. The product must be delivered in one-gallon bottles with a total shelf life of 36 months, ensuring at least 31 months remain upon delivery to the first government activity. Storage must be maintained at 25 degrees Fahrenheit, with permitted excursions between 15 and 30 degrees Celsius. The contract specifies delivery to the USS Harpers Ferry and USS Carter Hall, with a required delivery timeline of 20 days and FOB Destination terms. The contractor must adhere to strict packaging and marking standards, utilizing Medical Marking Standard No. 1 and MIL-STD-129. Hazardous materials must be packaged according to TQ requirement IP025 and FED-STD-313, and suppliers are required to submit Safety Data Sheets and Hazardous Communication Standard labels per 29 C.F.R. 1910.1200 prior to award. The contract is governed by various FAR and DFARS clauses, including requirements for safeguarding covered defense information, compliance with the Buy American Act, and the prohibition of covered defense telecommunications equipment. All payment requests must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

VARICELLA VIRUS VACCIN

Solicitation # SPE2DP-27-T-0243

Solicitation SPE2DP-27-T-0243 is a small business set-aside request for quotation issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of one package of lyophilized Varicella Virus Vaccine Live (NSN 6505-01-413-1331). Each package must contain 10 single dose vials of live vaccine and 10 vials of diluent, totaling 20 vials. The product, manufactured by Merck Sharp & Dohme LLC, is FDA regulated and must be drop shipped directly from the manufacturer to the destination in Camp Zama, Japan, within 20 days after order. The vaccine is a Type I Code K item with a non-extendable shelf life of 18 months, with a requirement that no more than 15 months have elapsed from the date of manufacture to the date of delivery. Strict storage and handling protocols are required, including maintaining a frozen temperature between -50C and -15C. Packaging must be commercial and comply with MIL-STD-2073-1E and Special Packaging Instructions MPPWN00001, while labeling must adhere to Medical Marking Standard No. 1B. Inspection and acceptance will occur at the destination per FAR 52.246-2. Invoicing and payment must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

GABAPENTIN CAPSULES

Solicitation # SPE2DP-27-T-0270

Solicitation SPE2DP-27-T-0270 is a Small Business Set-Aside procurement issued by the Defense Logistics Agency for the acquisition of 10 bottles of Gabapentin Capsules, 100 MG, in quantities of 100 per bottle. This FDA-regulated drug must be stored at 25C with permitted excursions between 15C and 30C per USP Controlled Room Temperature standards. The item has a non-extendable shelf life of 36 months. Delivery is required FOB Destination to a medical detachment in Washington, DC, with a required delivery date of November 12, 2026. The contract mandates commercial packaging and packing, requiring each unit to be in a sealed container to prevent damage, with shipping containers ensuring safe delivery. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and payment. The procurement incorporates various FAR and DFARS clauses, including the Buy American Act, NIST SP 800-171 cybersecurity requirements, and strict prohibitions on covered defense telecommunications equipment.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

AREDS2/Lutein/Zeaxanthin Supplement SupplyThis subcontract involves the manufacture and supply of Multivit/Ophth AREDS2/Lutein/Zeaxanthin capsules or tablets to support Department of Veterans Affairs pharmaceutical supply projects. The selected provider is responsible for sourcing or manufacturing the AREDS2 formula and ensuring a consistent, uninterrupted supply over a base year and four subsequent option years. Key requirements include the provision of a unique NDC number belonging to the offeror and strict compliance with all pharmaceutical labeling standards. The contractor is tasked with delivering the finished products directly to designated Prime Vendor distribution points to facilitate delivery to the end agency.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Pharmaceutical Labeling and Barcoding ServicesThis subcontract for Pharmaceutical Labeling and Barcoding Services involves the final packaging and preparation of Nitroglycerin patches for prime contractors serving the Department of Veterans Affairs and the Department of Defense. The scope of work includes boxing patches in 30-unit quantities, applying barcodes to both individual patches and outer boxes, and ensuring all unique NDC labels comply with FDA regulations. A critical requirement is that label adhesion must be managed to allow for subsequent VA over-labeling. The project is managed under Nac Pharmaceuticals for the Department of Veterans Affairs, falling under NAICS code 325412. The objective is to deliver retail-ready, fully barcoded, and labeled boxes of patches that meet all federal and agency specifications.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Nitroglycerin Transdermal Patch ManufacturingNac Pharmaceuticals is seeking a subcontractor to manufacture and supply Nitroglycerin transdermal patches in strengths of 0.1 mg, 0.2 mg, 0.4 mg, and 0.6 mg. These products are intended for prime contractors supporting Department of Veterans Affairs pharmaceutical supply contracts. The manufacturing process must utilize pharmaceutical grade Nitroglycerin API and adhere to FAR Part 12 commercial item standards. To be eligible, the provider must operate FDA-approved manufacturing facilities and ensure each product has a unique National Drug Code number. This subcontract opportunity falls under NAICS code 325412, with a response deadline of November 18, 2026.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

6505--Nitroglycerin Patches

Solicitation # 36E79727R0010

The Department of Veterans Affairs National Acquisition Center is initiating an unrestricted procurement for Nitroglycerin Patches under solicitation 36E79727R0010. This contract will serve the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award will be granted to a single responsible offeror capable of providing an uninterrupted source of supply for a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The procurement covers four strengths of Nitroglycerin patches (0.1 mg, 0.2 mg, 0.4 mg, and 0.6 mg), with estimated annual usage ranging from 2,213 to 10,044 boxes. All patches must be supplied in boxes of 30 and must feature barcoding on both the individual patch and the outside box. Strict labeling requirements apply: the contractor must provide a unique NDC number, and their label must be the only one on the product, without being affixed over another label. Additionally, the labels must allow VA labels to adhere securely over them. This solicitation will be issued in commercial item format per FAR Part 12, with a tentative issuance date of December 1, 2026, and a closing date of December 15, 2026.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

6505--AREDS2 ophthalmic multivitamins

Solicitation # 36E79727R0009

The Department of Veterans Affairs National Acquisition Center is initiating an unrestricted procurement under solicitation 36E79727R0009 for MULTIVIT/OPHTH AREDS2/LUTEIN/ZEAXANTHIN capsules or tablets. This contract is designed to provide an uninterrupted source of supply for the Department of Veterans Affairs, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The estimated annual requirement is 829,230 bottles of 120-count packaging, with distribution managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The contract will be awarded to a single responsible offeror for a base period of one year, followed by four pre-priced one-year option periods. The procurement follows FAR Part 12 commercial item format under NAICS code 325412. Strict labeling requirements apply: the contractor must provide a unique NDC number, and their label must be the only one on the product, with a prohibition against affixing labels over existing ones. The solicitation is expected to be issued electronically via SAM.gov on approximately December 23, 2026, with a tentative closing date of January 13, 2027.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Supply of Calcium Trisodium Pentetate (Ca-DTPA) Sterile InjectablesThis subcontract involves the supply of Calcium Trisodium Pentetate (Ca-DTPA) sterile injectables to prime contractors supporting medical countermeasure projects for the Government of Canada's Department of National Defence. The scope of work requires the manufacture and delivery of 750 to 1,250 sterile 5.0 mL ampoules, each containing between 1,000 mg and 1,055 mg of the active ingredient for intravenous injection. To be eligible, the provider must operate sterile pharmaceutical manufacturing facilities and hold valid marketing authorization from Health Canada, the US FDA, the EMA, or an EU member state. The contract is categorized under NAICS code 325412, with performance taking place in Canada. Responses to this opportunity are due by November 25, 2026.

Department of National Defence

POSTED

DEADLINE

Calcium Trisodium Pentetate (Ca-DTPA) ampoules

Solicitation # W6369-27-A062

The Department of National Defence, through the Strategic Medical Countermeasures Program on behalf of the Canadian Forces Health Services Group, is seeking the supply of Calcium Trisodium Pentetate (Ca-DTPA) ampoules to treat Canadian Armed Forces personnel exposed to radioactive transuranic elements such as plutonium, americium, and curium. The required product must be a sterile solution for intravenous injection containing 1,000 mg to 1,055 mg of active ingredient in a 5 mL ampoule, with a minimum shelf-life of 36 months from the date of manufacture. To ensure consistency with existing stockpiles for rapid emergency administration, the product must adhere to specific packaging and labelling standards and hold valid marketing authorization from Health Canada, the FDA, the EMA, or an EU member state. This procurement is being conducted via an Advance Contract Award Notice with an estimated total value of 47,500 CAD, including taxes and optional quantities. The contract is anticipated to run from the award date until March 31, 2031, featuring a firm requirement for 750 ampoules delivered in three annual increments of 250 starting no later than March 1, 2027. Additionally, the government has included an option for up to 500 more ampoules exercisable throughout the contract period. While Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG has been identified as the only known supplier capable of meeting these technical and regulatory requirements, other qualified suppliers may submit a Statement of Capabilities by November 25, 2026.

Department of National Defence

POSTED

DEADLINE

Pharmaceutical Grade Salicylic Acid SupplyThis subcontract involves the supply of high-purity, pharmaceutical-grade salicylic acid to prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The scope of work encompasses the chemical synthesis and purification of the acid to ensure it meets strict pharmaceutical standards for topical medical applications. All deliverables must be accompanied by SDS documentation and hold USP or equivalent pharmaceutical grade certifications. The project is categorized under NAICS code 325412 and is managed by the Medical Supply Chain MD Surg FSF. Performance of the contract is designated for FPO 09564. Interested parties should note the response deadline of November 16, 2026, for this bulk supply requirement.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Bismuth Subsalicylate Tablet SupplierThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA requires the provision of 55 packages of sugar-free Bismuth Subsalicylate tablets. Each unit must contain 48 individually sealed tablets formulated with 262 mg of Bismuth Subsalicylate and 140 mg of Calcium. The supplier is responsible for ensuring a 36-month shelf life and maintaining strict temperature controls to protect the product from heat exceeding 104 degrees Fahrenheit. The selected provider must be FDA registered and maintain full compliance with Medical Marking Standard No. 1 and MIL-STD-2073-1E. Performance for this contract will take place in Washington, with a response deadline set for November 16, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BISMUTH SUBSALICYLATE

Solicitation # SPE2DP-27-T-0266

This solicitation, issued by the Defense Logistics Agency (DLA) under number SPE2DP-27-T-0266, is a small business set-aside for the procurement of 55 packages of over-the-counter, sugar-free Bismuth Subsalicylate tablets. Each tablet must contain 262 mg of Bismuth Subsalicylate and 140 mg of Calcium, with each unit of issue consisting of 48 individually sealed tablets. The product has a total shelf life of 36 months, and a minimum of 31 months must remain at the time of receipt by the first government activity. To maintain product integrity, the supplies must be protected from excessive heat exceeding 104 degrees Fahrenheit or 40 degrees Celsius. The contract specifies that packaging and packing must be commercial, with each unit in a sealed container and shipped in suitable commercial exterior containers to ensure safe delivery. Marking and labeling must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and preservation must follow MIL-STD-2073-1E. Delivery is required FOB Destination to the DC ARNG MED DET in Washington, DC, with a delivery lead time of 20 days. Inspection and acceptance will occur at the destination. The procurement incorporates various FAR and DFARS clauses, including requirements for safeguarding covered defense information, NIST SP 800-171 assessment, and the Buy American Act. Invoicing must be processed electronically through the Wide Area Workflow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE